نتایج جستجو برای: pediatric aml and prognosis

تعداد نتایج: 16873517  

AS Hashemi , H Neamatzadeh, H Zare-Zardini , R Masoumi-Dehshiri ,

Acute myeloid leukemia (AML-M7) is a type of pediatric AML accounting for 3–10% of primary childhood AML and children may present with a broad variety of symptoms including low-grade fever, diarrhea, easy bruising, failure to gain weight and life-threatening conditions. We report a rare case of AML .A 26-month-old boy who presented with weakness and fatigue. He was diagnosed as a case of AMLM-7...

2014
Colleen E. Annesley Patrick Brown

Despite remarkable improvement in treatment outcomes in pediatric leukemia over the past several decades, the prognosis for high-risk groups of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), as well as for relapsed leukemia, remains poor. Intensification of chemotherapy regimens for those at highest risk has improved success rates, but at the cost of significantly increase...

babak abdolkarimi, Fazl Saleh, Mahdi Shahriari, Pooria Salajeghe,

Patients with acute myeloblastic leukemia (AML) with monosomy 7 are a group of patients with refractory AML who have a very poor prognosis. Therefore, rationally designed new therapies, including metronomic chemotherapy regimen with histidine deacetylase inhibitors (Valporic acid, ATRA) are being investigated as potential treatments for the population of refractory cases of AML. Herein, we repo...

Journal: :Blood 2011
Phoenix A Ho Kenneth J Kopecky Todd A Alonzo Robert B Gerbing Kristen L Miller Julia Kuhn Rong Zeng Rhonda E Ries Susana C Raimondi Betsy A Hirsch Vivian Oehler Craig A Hurwitz Janet L Franklin Alan S Gamis Stephen H Petersdorf Jeanne E Anderson John E Godwin Gregory H Reaman Cheryl L Willman Irwin D Bernstein Jerald P Radich Frederick R Appelbaum Derek L Stirewalt Soheil Meshinchi

IDH1 SNP rs11554137 was recently reported in association with poor prognosis in normal karyotype adult acute myeloid leukemia (AML). We aimed to determine the prevalence, clinical associations, and prognostic significance of SNP rs11554137 in unselected pediatric and adult AML patients. Diagnostic marrow specimens from 527 AML patients treated on the pediatric trial Children's Oncology Group-AA...

Journal: :Haematologica 2007
Gertjan J L Kaspers Christian M Zwaan

Prognosis of childhood acute myeloid leukemia (AML) has improved significantly over the past decades, from nearly no child surviving to a present probability of cure of approximately 60%. However, this can only be achieved using very intensive chemotherapy which results in relatively high rates of treatment related deaths and significant late effects. This review summarizes current and future c...

Journal: :Blood 2010
Hendrik J M de Jonge Peter J M Valk Nic J G M Veeger Arja ter Elst Monique L den Boer Jacqueline Cloos Valérie de Haas Marry M van den Heuvel-Eibrink Gertjan J L Kaspers Christian M Zwaan Willem A Kamps Bob Löwenberg Eveline S J M de Bont

High VEGFC mRNA expression of acute myeloid leukemia (AML) blasts is related to increased in vitro and in vivo drug resistance. Prognostic significance of VEGFC on long-term outcome and its associated gene expression profiles remain to be defined. We studied effect of VEGFC on treatment outcome and investigated gene expression profiles associated with VEGFC using microarray data of 525 adult an...

2012
Jin Bai Aiping Guo Ze Hong Wenxia Kuai

OBJECTIVE MicroRNA-100 (miR-100), a small noncoding RNA molecule, acts as a tumor suppressor or an oncogene in different cancers. The aberrant expression of this microRNA has been demonstrated as a frequent event in adult patients with acute myeloid leukemia (AML), but little is known for pediatric AML. The aim of this study was to investigate the expression and clinical significance of miR-100...

Journal: :Annals of laboratory medicine 2016
Min-Gu Kang Yu-Na Kim Jun Hyung Lee Michael Szardenings Hee-Jo Baek Hoon Kook Hye-Ran Kim Myung-Geun Shin

BACKGROUND To the best of our knowledge, the association between pediatric AML and mitochondrial aberrations has not been studied. We investigated various mitochondrial aberrations in pediatric AML and evaluated their impact on clinical outcomes. METHODS Sequencing, mitochondrial DNA (mtDNA) copy number determination, mtDNA 4,977-bp large deletion assessments, and gene scan analyses were perf...

2016
Lonneke J. Verboon Askar Obulkasim Jasmijn D.E. de Rooij Jenny E. Katsman Edwin Sonneveld André Baruchel Jan Trka Dirk Reinhardt Rob Pieters Jacqueline Cloos Gertjan J.L. Kaspers Jan-Henning Klusmann Christian Michel Zwaan Maarten Fornerod Marry M. van den Heuvel-Eibrink

The most important reason for therapy failure in pediatric acute myeloid leukemia (AML) is relapse. In order to identify miRNAs that contribute to the clonal evolution towards relapse in pediatric AML, miRNA expression profiling of 127 de novo pediatric AML cases were used. In the diagnostic phase, no miRNA signatures could be identified that were predictive for relapse occurrence, in a large p...

2016
Ivan Petrov Maria Suntsova Olga Mutorova Maxim Sorokin Andrew Garazha Elena Ilnitskaya Pavel Spirin Sergey Larin Alex Zhavoronkov Olga Kovalchuk Vladimir Prassolov Alexander Roumiantsev Anton Buzdin

Acute lymphoblast leukemia (ALL) is characterized by overproduction of immature white blood cells in the bone marrow. ALL is most common in the childhood and has high (>80%) cure rate. In contrast, acute myeloid leukemia (AML) has far greater mortality rate than the ALL and is most commonly affecting older adults. However, AML is a leading cause of childhood cancer mortality. In this study, we ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید